Publications by authors named "David Sp Tan"

Claim this Profile
U
Uterine leiomyosarcoma.
Giorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, Pedro T Ramirez, Nicole Concin, David Sp Tan

Int J Gynecol Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment.
Felix Blanc-Durand, Natalie Ngoi, Diana Lim, Isabelle Ray-Coquard, David Sp Tan

Cancer Treat Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological characteristics associated with of loss-of-heterozygosity in endometrial cancer.
Felix Blanc-Durand, Etienne Rouleau, Patricia Pautier, Natalie Ngoi, Yi Wan Lim, David Sp Tan

J Gynecol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia.
Ava Kwong, David S-P Tan, Jai Min Ryu,

Asia Pac J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.
Silvana Talisa Wijaya, Natalie Yl Ngoi, Jerold Wz Loh, Tuan Zea Tan, Diana Lim, David Sp Tan

J Gynecol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4.
Yoo-Na Kim, Boram Park, Jae Weon Kim, Byoung Gie Kim, Sang Wun Kim, David Sp Tan

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality management of advanced cervical cancer including novel sensitizers.
Michelle Tseng, Natalie Yl Ngoi, David Sp Tan, Pearl Sy Tong

Int J Gynecol Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.
Natalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, Boon Cher Goh, Ruby Yun-Ju Huang, David Sp Tan

Cochrane Database Syst Rev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of molecular tests for adjuvant and post-surgical treatment in gynaecological cancers.
Silvana Talisa Wijaya, Natalie Yl Ngoi, David Sp Tan

Best Pract Res Clin Obstet Gynaecol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma.
Valerie Heong, Tuan Z Tan, Maiko Miwa, Jieru Ye, Diana Lim, David Sp Tan

J Pathol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with -mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore.
David Sp Tan, Jack Junjie Chan, Robert Hettle, Wrik Ghosh, Amrita Viswambaram

J Gynecol Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01).
Yong Jae Lee, Myong Cheol Lim, Byoung Gie Kim, Natalie Yl Ngoi, Chel Hun Choi, David Sp Tan

J Gynecol Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting replicative stress in gynecological cancers as a therapeutic strategy.
Natalie Yl Ngoi, Vignesh Sundararajan, David Sp Tan

Int J Gynecol Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA).
Natalie Yl Ngoi, Valerie Heong, Samuel Ow, Wen Yee Chay, Hee Seung Kim, David Sp Tan

Int J Gynecol Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique.
Valerie Heong, Darwin Tay, Shane Ee Goh, Bernard Wee, Tuan Zea Tan, David Sp Tan

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asian Society of Gynecologic Oncology International Workshop 2018.
Tae Wook Kong, Hee Sug Ryu, Seung Cheol Kim, Takayuki Enomoto, Jin Li, David Sp Tan

J Gynecol Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers.
Natalie Yl Ngoi, David Sp Tan

J Gynecol Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
Matilda X Lee, David Sp Tan

J Gynecol Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis